查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1929634

半月软骨修復锚钉市场按类型、材料、应用和最终用户划分，全球预测（2026-2032年）

Meniscus Repair Anchor Market by Type, Material, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025 年半月软骨修復锚钉市场价值为 5.5812 亿美元，预计到 2026 年将成长至 6.0316 亿美元，到 2032 年预计将达到 9.1637 亿美元，复合年增长率为 7.34%。

主要市场统计数据
基准年 2025 5.5812亿美元
预计年份：2026年 6.0316亿美元
预测年份：2032年 9.1637亿美元
复合年增长率 (%) 7.34%

探讨临床优先事项、手术效率和商业性压力如何重塑半月软骨修復锚钉的研发和应用。

半月软骨修復锚钉市场正经历着一个以临床证据、不断发展的外科技术和医疗服务管道变革为驱动力的稳健创新阶段。旨在恢復膝关节稳定性和功能的器械，其评估标准不仅包括固定强度和生物相容性，还包括与关节镜流程的整合、器械的人体工学设计以及与注重成本效益的医疗路径的兼容性。外科医生和采购相关人员优先考虑的是那些能够提供可靠临床疗效，同时又能简化手术室时间和库存管理的解决方案。

临床进展、材料创新和以价值为导向的医疗保健服务如何融合，从而改变半月软骨修復锚定策略和市场动态

近年来，临床实践、材料科学和医疗服务领域发生了变革性变化，重塑了半月软骨修復锚钉的模式。随着训练项目和医疗设备研发人员不断降低术中复杂性，微创关节镜手术技术持续发展，能够更精准地修復复杂的断裂模式，并扩大适应症。锚钉形状和输送系统的同步进步提高了操作灵活性，而生物可吸收聚合物的改进则增强了外科医生的信心，使他们相信无需永久性金属部件即可实现长期的组织整合。

评估2025年关税主导的供应链变化和贸易政策调整对医疗设备价值链采购行为、筹资策略和成本压力的影响

近期政策週期中关税的征收和贸易政策的动态对医疗设备的采购、零件供应和定价产生了连锁反应，为2025年后的战略规划奠定了关键基础。影响原材料、成品和中间零件的关税增加了许多医疗设备製造商的到岸成本，迫使他们重新审视供应商合同，考虑其他采购地区，并与机构买家进行价格谈判。这些成本压力促使采购团队更密切地关注总体拥有成本，包括器械耐用性、再次手术率以及影响治疗经济效益的营运效率。

详细的細項分析揭示了设备类型、材料选择、临床方法和最终用户环境如何相互作用，从而塑造采用模式和商业性定位。

分析揭示了不同器械类型、材料、临床适应症和临床环境的采用和发展轨迹。对全内入路、由内向外入路、由外向内入路和膝盖骨修復技术的分析表明，针对微创关节关节镜流程优化的器械在视野清晰和软组织处理至关重要的领域越来越受到临床医生的青睐。在手术量大的环境中，能够减少打结、简化器械操作和缩短手术时间的设计选择尤其受到重视。

区域比较分析解释了临床实践、报销复杂性和供应链因素如何影响全球市场的产品采用。

区域趋势显示，临床实务模式、报销架构和供应链物流存在显着差异，这些差异会影响产品策略和商业化计画。在美洲，医疗机构对微创技术的广泛应用以及集中化的门诊护理中心网络，为那些展现出显着手术效率和可持续治疗效果的医疗器械创造了广阔的市场机会。该地区的支付方谈判和医院采购流程均强调，比较临床证据和生命週期成本是决定产品采纳的关键因素。

决定市场定位的关键竞争动态和公司层面策略：产品设计、临床证据和供应链韧性

半月软骨固定器械领域的竞争格局由成熟的整形外科公司和灵活的专业器械製造商组成，后者透过材料科学、器械设计和外科医生培训计画来脱颖而出。成熟的製造商往往利用广泛的分销网络和丰富的临床证据来维持其在医院系统和大型采购集团中的优先供应权。而小规模的创新者则倾向于透过新颖的输送机制、简化的手术流程以及展现特定领域优势的针对性临床数据来展开竞争。

为製造商和医疗服务提供者领导者提供如何协调临床证据、价值链策略和商业模式以实现持续应用和价值交付的实用建议

产业领导者应采取将产品创新与实证医学、供应链稳健性和客製化商业模式结合的方法。优先投资于临床研究和註册登记，将锚定选择与以患者为中心的有意义的疗效和手术效率联繫起来，从而促进采购方和支付方之间超越单价比较的对话。同时，优化手术器械，减少操作步骤，并鼓励那些追求速度和精准度的外科医生采用这些器械。

本分析所依据的调查方法将以透明的方式进行解释，采用混合方法，结合临床医师访谈、文献综合和相关人员检验检验研究结果。

本分析的研究结合了定性访谈、文献综述以及对临床和采购趋势的系统性综合分析，建构了一个连贯的证据体系。主要数据包括与骨科医生、门诊和住院采购经理以及医疗设备研发专家的结构化访谈，旨在收集真实世界的案例、推广障碍和临床偏好。次要资讯则来自同侪审查的临床研究、监管指南和公共卫生政策文件，以支持对临床性能和安全性的考虑。

结论部分概述了以证据为导向的产品设计、协作和稳健的供应链策略如何决定产品的长期应用和商业性成功。

分析结论认为，半月软骨修復锚钉领域的持续商业性成功将有利于那些将成熟的临床性能与实际考虑（例如手术效率、供应链韧性以及满足终端用户操作需求）相结合的解决方案。优先考虑锚钉选择能够改善患者预后并减轻手术负担的证据的器械製造商，将更有利于吸引註重性价比的买家并抵御价格压力。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 市场进入策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章 美国关税的累积影响，2025年

第七章 人工智慧的累积影响，2025年

第八章半月软骨修復锚钉市场（按类型划分）

  • 全部内容
  • 脑筋急转弯
  • 由外向内
  • 经髌骨入路

第九章半月软骨修復锚钉市场（依材料分类）

  • 生物可吸收聚合物
  • 钛

第十章半月软骨修復锚钉市场（按应用领域划分）

  • 关节镜
  • 开放性手术

第十一章半月软骨修復锚钉市场（按最终用户划分）

  • 门诊手术中心
  • 医院
  • 专科诊所

第十二章 各地区半月软骨修復锚钉市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章半月软骨修復锚钉市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 各国半月软骨修復锚定市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

16. 美国半月软骨修復锚钉市场

第十七章 中国半月软骨修復锚钉市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Aesculap Implant Systems GmbH
  • Arthrex, Inc.
  • B. Braun Melsungen AG
  • Biosuture Inc.
  • CONMED Corporation
  • ConMed Linvatec
  • DJO Global, Inc.
  • Exactech, Inc.
  • Globus Medical, Inc.
  • Heraeus Medical GmbH
  • Integra LifeSciences Holdings Corporation
  • Medtronic plc
  • Neoligaments Ltd.
  • Olympus Corporation
  • Orthomed Medical Ltd.
  • OrthoSpace Ltd.
  • Parcus Medical, LLC
  • Smith & Nephew Orthopaedics Ltd.
  • Smith & Nephew plc
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-0A380695185D

The Meniscus Repair Anchor Market was valued at USD 558.12 million in 2025 and is projected to grow to USD 603.16 million in 2026, with a CAGR of 7.34%, reaching USD 916.37 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 558.12 million
Estimated Year [2026] USD 603.16 million
Forecast Year [2032] USD 916.37 million
CAGR (%) 7.34%

Introduction framing the clinical priorities, procedural efficiencies, and commercial pressures that are reshaping meniscus repair anchor development and adoption

The landscape for meniscus repair anchors is undergoing a period of disciplined innovation driven by clinical evidence, surgical technique evolution, and shifting healthcare delivery channels. Devices designed to restore knee stability and function are increasingly evaluated not only on fixation strength and biocompatibility but also on how they integrate with arthroscopic workflows, instrumentation ergonomics, and cost-conscious care pathways. Surgeons and purchasing stakeholders alike are prioritizing solutions that offer reliable clinical outcomes while streamlining operating room time and inventory complexity.

This introduction establishes the foundational context for subsequent analysis by highlighting the confluence of clinical imperatives and commercial pressures. The growing preference for minimally invasive arthroscopic procedures, the maturation of bioabsorbable materials, and the heightened scrutiny of total episode costs collectively define the decision criteria that manufacturers, payers, and providers must navigate. Transitioning from traditional open techniques to refined arthroscopic approaches has magnified the importance of anchor design, delivery systems, and surgeon training programs. As stakeholders seek to balance clinical efficacy with procedural efficiency, strategic choices across product development, market access, and post-market evidence generation will determine which technologies achieve sustained adoption.

How clinical technique evolution, materials innovation, and value-driven care delivery are converging to transform meniscus repair anchor strategy and market dynamics

Recent years have witnessed transformative shifts across clinical practice, materials science, and care delivery that are redefining the meniscus repair anchor landscape. Minimally invasive arthroscopic techniques have continued to expand as training programs and device innovators reduce intraoperative complexity, enabling more consistent repair of complex tear patterns and extending indications to broader patient cohorts. Parallel advances in anchor geometries and delivery systems have improved handling characteristics, while the refinement of bioabsorbable polymers has accelerated surgeon confidence in long-term tissue integration without permanent hardware burden.

Concurrently, procedural migration toward ambulatory settings has placed a premium on implants that reduce operating room time and simplify inventory management. Payers and provider networks are pursuing value-based arrangements that reward durable clinical outcomes and cost containment, prompting manufacturers to align clinical evidence generation with health economics narratives. Supply chain resilience has also emerged as a competitive differentiator, with companies investing in diversified sourcing strategies and production agility. Taken together, these shifts favor manufacturers that can couple robust clinical data with pragmatic device design, scalable manufacturing, and responsive commercial models that meet the practical needs of surgeons and healthcare systems.

Assessment of how tariff-driven supply chain shifts and trade policy adjustments in 2025 have influenced procurement behavior, sourcing strategy, and cost pressures across the device value chain

The imposition of tariffs and trade policy changes in recent policy cycles has had a cascading effect across medical device procurement, component sourcing, and pricing dynamics, creating a material context for strategic planning in 2025 and beyond. Tariffs that affect raw materials, finished goods, and intermediate components have raised landed costs for many device manufacturers, compelling reviews of supplier contracts, alternative sourcing geographies, and price negotiations with institutional purchasers. These cost pressures have prompted procurement teams to scrutinize total cost of ownership more closely, including device durability, reoperation rates, and operational efficiency that influence episode-of-care economics.

In response to tariff-driven inflationary pressures, several manufacturers accelerated supply chain reconfiguration efforts that prioritize nearshoring and multi-sourcing strategies. This has led to selective onshoring of critical production steps and investments in local inventory buffers to protect against volatility. Payers and health systems, meanwhile, have intensified demand for demonstrable value, placing performance and cost-effectiveness at the center of purchasing decisions. For clinical leaders, the practical consequence is a heightened emphasis on evidence that connects anchor choice with measurable improvements in procedural efficiency and patient outcomes, enabling stakeholders to justify premium pricing where clinical and economic benefits are substantiated.

Detailed segmentation insights that explain how device type, material selection, clinical approach, and end-user environment jointly shape adoption patterns and commercial positioning

Segmentation-driven insights reveal differentiated adoption and development trajectories across device types, materials, clinical indications, and care settings. Analysis across All-Inside, Inside-Out, Outside-In, and Trans-Patellar repair techniques shows that devices optimized for minimally invasive arthroscopic workflows are capturing increased clinician preference where visualization and soft-tissue handling are critical. Design choices that reduce knot tying, simplify passage, and shorten operative time are particularly valued in settings with high procedural throughput.

Material selection between bioabsorbable polymer and titanium anchors remains a pivotal factor influencing clinical choice and product positioning. Bioabsorbable polymer technologies appeal to stakeholders focused on long-term tissue remodeling and minimizing permanent hardware, while titanium anchors retain strength and predictable fixation, especially in complex repairs or patients with higher biomechanical demands. Application context, whether arthroscopic or open, drives product configuration and instrumentation needs; arthroscopic applications prioritize low-profile delivery and modular instrumentation, whereas open repairs emphasize robust fixation options and straightforward implantation.

End user dynamics across Ambulatory Surgical Centers, Hospitals, and Specialty Clinics further modulate purchasing behaviors and implementation timelines. Ambulatory settings prioritize cost-efficiency and devices that streamline turnover, hospitals emphasize comprehensive clinical evidence and multi-disciplinary procurement processes, and specialty clinics focus on patient throughput and surgeon preference continuity. Together, these segmentation layers inform how manufacturers should tailor evidence generation, commercial models, and training programs to address distinct clinical workflows and procurement criteria.

Comparative regional analysis describing how clinical practice, reimbursement complexity, and supply chain considerations influence product adoption across global markets

Regional dynamics exhibit meaningful variance in clinical practice patterns, reimbursement frameworks, and supply chain logistics that influence product strategies and commercialization plans. In the Americas, strong institutional adoption of minimally invasive techniques and a concentrated network of ambulatory centers create fertile opportunities for devices that demonstrate clear procedural efficiency and durable outcomes. Payor negotiations and hospital procurement processes in this region emphasize comparative clinical evidence and lifecycle cost considerations as key determinants of adoption.

Europe, Middle East & Africa presents a fragmented regulatory and reimbursement landscape with a blend of centralized and localized purchasing behaviors. Clinical practice in many countries within this region emphasizes long-term outcomes and cost-effectiveness, which elevates the importance of robust clinical registries and multi-center evidence. Supply chain complexity and variable import duties across jurisdictions necessitate adaptable distribution strategies and local partnerships to ensure timely access.

Asia-Pacific is characterized by rapid surgical volume growth, expanding hospital infrastructure, and an increasing number of ambulatory facilities. Manufacturers that invest in surgeon education, local clinical data generation, and flexible pricing structures can accelerate uptake. Across all regions, resilience in logistics, responsiveness to regulatory variations, and the capacity to support post-market surveillance are central to sustained commercial success.

Key competitive dynamics and company-level strategies that reveal how product design, clinical evidence, and supply chain resilience determine market positioning

Competitive dynamics in the meniscus anchor domain are shaped by a blend of legacy orthopedic firms and agile specialty device companies that differentiate through materials science, instrumentation design, and surgeon education programs. Established manufacturers often leverage extensive distribution networks and clinical evidence portfolios to maintain preferential access in hospital systems and large purchasing groups, while smaller innovators tend to compete on novel delivery mechanisms, simplified surgical workflows, and targeted clinical data that demonstrate niche advantages.

Strategic partnerships between clinical centers of excellence and manufacturers have become a focal point for accelerating evidence generation and surgeon adoption. Companies that invest in high-quality post-market surveillance, registry data, and peer-to-peer training programs strengthen clinician confidence and facilitate guideline inclusion. At the same time, supply chain capabilities, including contract manufacturing agility and inventory management, are critical differentiators given recent disruptions and tariff-related cost pressures. Intellectual property around anchor geometry, fixation chemistry, and deployment systems continues to influence competitive positioning, and firms that align product design with real-world efficiency metrics are more likely to secure favorable procurement outcomes.

Actionable recommendations for manufacturers and provider leaders to align clinical evidence, supply chain strategy, and commercial models for sustained adoption and value delivery

Industry leaders should pursue an integrated approach that aligns product innovation with evidence generation, supply chain robustness, and tailored commercial models. Prioritize investment in clinical studies and registries that link anchor selection to meaningful patient-centered outcomes and procedure-level efficiencies, thereby enabling procurement and payer conversations that transcend unit price comparisons. Concurrently, streamline instrumentation to reduce operative steps and facilitate adoption among surgeons who balance speed and precision.

On the supply side, diversify sourcing and evaluate nearshoring opportunities to mitigate tariff and logistics risk while preserving cost competitiveness. Strengthen surgeon engagement through focused training programs and modular educational content that accelerates proficiency in contemporary arthroscopic techniques. Commercial teams should tailor pricing and contracting strategies to specific end-user environments, offering flexible bundles for ambulatory centers, integrated value propositions for hospital systems, and practice-level solutions for specialty clinics. Finally, integrate health economic modeling into pre-launch planning to articulate total episode benefits and to support premium positioning where justified by robust evidence.

Transparent explanation of the mixed-methods research approach combining clinician interviews, literature synthesis, and cross-stakeholder triangulation to validate insights

The research underpinning this analysis integrates primary qualitative interviews, secondary literature review, and a structured synthesis of clinical and procurement trends to build a coherent evidence narrative. Primary inputs included structured discussions with orthopedic surgeons, procurement leaders across ambulatory and hospital settings, and device development specialists to capture real-world use cases, adoption barriers, and clinical preferences. Secondary sources were drawn from peer-reviewed clinical studies, regulatory guidance, and public health policy documents to corroborate clinical performance and safety considerations.

Findings were validated through triangulation across multiple stakeholder perspectives to ensure balanced interpretation of clinical and commercial signals. The methodology prioritized transparency in data provenance, clear articulation of assumptions, and cross-validation of insights against observed adoption patterns and supply chain behaviors. Where necessary, sensitivity checks were performed to assess the robustness of conclusions against alternative interpretations of clinical practice evolution and procurement dynamics. This layered approach supports a pragmatic set of conclusions and recommendations that reflect both clinical realities and marketplace constraints.

Conclusion summarizing how evidence-driven product design, operational alignment, and resilient supply strategies together determine long-term adoption and commercial success

This analysis concludes that durable commercial success in the meniscus repair anchor space will favor solutions that integrate proven clinical performance with pragmatic considerations for procedure efficiency, supply chain resilience, and alignment to end-user operational needs. Device producers that emphasize evidence linking anchor selection to improved patient outcomes and reduced procedural burden will be best positioned to engage with value-focused purchasers and to withstand pricing pressures.

Moreover, the interplay of material selection, delivery system design, and targeted education will determine the pace and breadth of adoption across care settings. Manufacturers must balance innovation with pragmatic implementation strategies that reduce friction for surgeons and procurement teams. In short, the path to sustained adoption is paved by a combination of robust clinical data, thoughtful commercial models, and operational capabilities that ensure timely, cost-effective access for providers and patients alike.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Meniscus Repair Anchor Market, by Type

  • 8.1. All-Inside
  • 8.2. Inside-Out
  • 8.3. Outside-In
  • 8.4. Trans-Patellar

9. Meniscus Repair Anchor Market, by Material

  • 9.1. Bioabsorbable Polymer
  • 9.2. Titanium

10. Meniscus Repair Anchor Market, by Application

  • 10.1. Arthroscopic
  • 10.2. Open

11. Meniscus Repair Anchor Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Hospitals
  • 11.3. Specialty Clinics

12. Meniscus Repair Anchor Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Meniscus Repair Anchor Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Meniscus Repair Anchor Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Meniscus Repair Anchor Market

16. China Meniscus Repair Anchor Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Aesculap Implant Systems GmbH
  • 17.6. Arthrex, Inc.
  • 17.7. B. Braun Melsungen AG
  • 17.8. Biosuture Inc.
  • 17.9. CONMED Corporation
  • 17.10. ConMed Linvatec
  • 17.11. DJO Global, Inc.
  • 17.12. Exactech, Inc.
  • 17.13. Globus Medical, Inc.
  • 17.14. Heraeus Medical GmbH
  • 17.15. Integra LifeSciences Holdings Corporation
  • 17.16. Medtronic plc
  • 17.17. Neoligaments Ltd.
  • 17.18. Olympus Corporation
  • 17.19. Orthomed Medical Ltd.
  • 17.20. OrthoSpace Ltd.
  • 17.21. Parcus Medical, LLC
  • 17.22. Smith & Nephew Orthopaedics Ltd.
  • 17.23. Smith & Nephew plc
  • 17.24. Stryker Corporation
  • 17.25. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MENISCUS REPAIR ANCHOR MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL MENISCUS REPAIR ANCHOR MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES MENISCUS REPAIR ANCHOR MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA MENISCUS REPAIR ANCHOR MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY ALL-INSIDE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY ALL-INSIDE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY ALL-INSIDE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY INSIDE-OUT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY INSIDE-OUT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY INSIDE-OUT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY OUTSIDE-IN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY OUTSIDE-IN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY OUTSIDE-IN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY TRANS-PATELLAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY TRANS-PATELLAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY TRANS-PATELLAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY BIOABSORBABLE POLYMER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY BIOABSORBABLE POLYMER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY BIOABSORBABLE POLYMER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY TITANIUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY TITANIUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY TITANIUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY ARTHROSCOPIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY ARTHROSCOPIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY ARTHROSCOPIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY OPEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY OPEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY OPEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. AMERICAS MENISCUS REPAIR ANCHOR MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 41. AMERICAS MENISCUS REPAIR ANCHOR MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 42. AMERICAS MENISCUS REPAIR ANCHOR MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 43. AMERICAS MENISCUS REPAIR ANCHOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 44. AMERICAS MENISCUS REPAIR ANCHOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 45. NORTH AMERICA MENISCUS REPAIR ANCHOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. NORTH AMERICA MENISCUS REPAIR ANCHOR MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 47. NORTH AMERICA MENISCUS REPAIR ANCHOR MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 48. NORTH AMERICA MENISCUS REPAIR ANCHOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 49. NORTH AMERICA MENISCUS REPAIR ANCHOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 50. LATIN AMERICA MENISCUS REPAIR ANCHOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. LATIN AMERICA MENISCUS REPAIR ANCHOR MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 52. LATIN AMERICA MENISCUS REPAIR ANCHOR MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 53. LATIN AMERICA MENISCUS REPAIR ANCHOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 54. LATIN AMERICA MENISCUS REPAIR ANCHOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA MENISCUS REPAIR ANCHOR MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA MENISCUS REPAIR ANCHOR MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA MENISCUS REPAIR ANCHOR MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA MENISCUS REPAIR ANCHOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA MENISCUS REPAIR ANCHOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 60. EUROPE MENISCUS REPAIR ANCHOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. EUROPE MENISCUS REPAIR ANCHOR MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 62. EUROPE MENISCUS REPAIR ANCHOR MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 63. EUROPE MENISCUS REPAIR ANCHOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 64. EUROPE MENISCUS REPAIR ANCHOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 65. MIDDLE EAST MENISCUS REPAIR ANCHOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. MIDDLE EAST MENISCUS REPAIR ANCHOR MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 67. MIDDLE EAST MENISCUS REPAIR ANCHOR MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 68. MIDDLE EAST MENISCUS REPAIR ANCHOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 69. MIDDLE EAST MENISCUS REPAIR ANCHOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 70. AFRICA MENISCUS REPAIR ANCHOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. AFRICA MENISCUS REPAIR ANCHOR MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 72. AFRICA MENISCUS REPAIR ANCHOR MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 73. AFRICA MENISCUS REPAIR ANCHOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 74. AFRICA MENISCUS REPAIR ANCHOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC MENISCUS REPAIR ANCHOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC MENISCUS REPAIR ANCHOR MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC MENISCUS REPAIR ANCHOR MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC MENISCUS REPAIR ANCHOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC MENISCUS REPAIR ANCHOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. ASEAN MENISCUS REPAIR ANCHOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. ASEAN MENISCUS REPAIR ANCHOR MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 83. ASEAN MENISCUS REPAIR ANCHOR MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 84. ASEAN MENISCUS REPAIR ANCHOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 85. ASEAN MENISCUS REPAIR ANCHOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 86. GCC MENISCUS REPAIR ANCHOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GCC MENISCUS REPAIR ANCHOR MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. GCC MENISCUS REPAIR ANCHOR MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 89. GCC MENISCUS REPAIR ANCHOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 90. GCC MENISCUS REPAIR ANCHOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPEAN UNION MENISCUS REPAIR ANCHOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPEAN UNION MENISCUS REPAIR ANCHOR MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPEAN UNION MENISCUS REPAIR ANCHOR MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPEAN UNION MENISCUS REPAIR ANCHOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPEAN UNION MENISCUS REPAIR ANCHOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 96. BRICS MENISCUS REPAIR ANCHOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. BRICS MENISCUS REPAIR ANCHOR MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. BRICS MENISCUS REPAIR ANCHOR MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 99. BRICS MENISCUS REPAIR ANCHOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 100. BRICS MENISCUS REPAIR ANCHOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. G7 MENISCUS REPAIR ANCHOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. G7 MENISCUS REPAIR ANCHOR MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. G7 MENISCUS REPAIR ANCHOR MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 104. G7 MENISCUS REPAIR ANCHOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 105. G7 MENISCUS REPAIR ANCHOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. NATO MENISCUS REPAIR ANCHOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. NATO MENISCUS REPAIR ANCHOR MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 108. NATO MENISCUS REPAIR ANCHOR MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 109. NATO MENISCUS REPAIR ANCHOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 110. NATO MENISCUS REPAIR ANCHOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. UNITED STATES MENISCUS REPAIR ANCHOR MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 113. UNITED STATES MENISCUS REPAIR ANCHOR MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. UNITED STATES MENISCUS REPAIR ANCHOR MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 115. UNITED STATES MENISCUS REPAIR ANCHOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 116. UNITED STATES MENISCUS REPAIR ANCHOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 117. CHINA MENISCUS REPAIR ANCHOR MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 118. CHINA MENISCUS REPAIR ANCHOR MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. CHINA MENISCUS REPAIR ANCHOR MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 120. CHINA MENISCUS REPAIR ANCHOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 121. CHINA MENISCUS REPAIR ANCHOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)